Among the companies with shares expected to actively trade in
Friday's session are Google Inc. (GOOG), Microsoft Corp. (MSFT) and
Community Health Systems Inc. (CYH).
Google's profit and sales continued to climb in the recent
quarter, but deceleration in the growth of its main business of
selling search advertising reignited concerns about the impact of
mobile devices and the Web giant's push into lower-margin
businesses. The results were lower than what Wall Street was
expecting, sending shares down 4.6% to $869.00 after hours.
Microsoft took a $900 million charge related to slashing the
price of its struggling Surface tablet computer, highlighting the
company's struggle to fit into the new tech world dominated by
mobile devices. The software giant revealed the charge with its
fourth-quarter report, which fell below Wall Street expectations
and sent Microsoft shares sharply lower in after-hours trading.
Hospital operator Community Health slashed its second-quarter
earnings forecast and said it was served with an additional
subpoena from the government as part of an investigation into
Medicare admissions. The double dose of bad news sent shares of
Community Health and its peers sharply lower in after-hours
trading. Community Health shares slumped 18% to $38.97. Also
sliding were shares of Health Management Associates Inc. (HMA),
Tenet Healthcare Corp. (THC) and HCA Holdings Inc. (HCA), all of
which fell 3% or more.
Acacia Research Corp. (ACTG) reported a second-quarter loss as
legal fees and other costs cut into the company's revenue from
patents. Shares, trading in which was briefly halted on the news,
dropped 15% after hours to $21.
Advanced Micro Devices Inc. (AMD) swung to a second-quarter loss
as the chip maker continued to suffer sales declines on lower
demand for personal computers. Shares fell 4.1% after hours to
$4.45.
Align Technology Inc.'s (ALGN) second-quarter earnings rose 2.9%
as the maker of Invisalign braces posted increased revenue on
higher shipments. Shares were up 6.2% at $42.10 after hours as the
company's results beat estimates.
Medical products maker Hologic Inc. (HOLX) said Robert Cascella
has stepped down as chief executive for personal reasons, and the
company has brought back Jack W. Cumming. Shares were up 2.7% to
$20.51 after hours.
ICU Medical Inc.'s (ICUI) second-quarter earnings fell 19% as
the medical-products maker recorded lower sales from its
critical-care business. Shares fell 6.2% after hours to $70 as the
company also lowered its full-year outlook.
Intuitive Surgical Inc. (ISRG) slashed its forecast for sales
growth this year as the company deals with increasing concerns
about its da Vinci surgical robot systems. Shares of the Sunnyvale,
Calif., company fell 12% to $370.70 after hours as Intuitive
Surgical disclosed a number of issues that have derailed growth in
the use of its robots to perform hysterectomies, a primary catalyst
for sales of the company's systems and surgical instruments.
Oxigene Inc. (OXGN) said the European Medicines Agency has
granted orphan drug status to its ovarian cancer treatment
Zybrestat. The biopharmaceutical company's shares soared 28% to
$3.21 after hours.
Specialty pharmaceutical firm pSivida Corp. (PSDV, PVA.AU) said
it intends to offer shares, but didn't name a time or an amount.
PSivida develops drugs to treat diseases in the back of the eye.
Shares were off 5% after hours to $3.25.
Skyworks Solutions Inc.'s (SWKS) fiscal third-quarter earnings
rose 33% as the wireless-chip supplier continued to see strong
demand across a range of end markets. Shares jumped 6.7% to $23.95
after hours as results exceeded the company's estimates and as it
provided upbeat guidance for the current quarter.
Watchlist:
Apache Corp. (APA) has agreed to sell its Gulf of Mexico shelf
operations and properties to Fieldwood Energy LLC for $3.75 billion
in cash, as the U.S. oil and gas company looks to pay down
debt.
Capital One Financial Corp.'s (COF) second-quarter profit soared
from a year earlier as the credit-card lender's provision for
credit losses fell and revenue increased slightly. The lender's
results topped analyst expectations.
Cepheid's (CPHD) swung to second-quarter loss as the maker of
molecular tests for the health-care industry was hurt by higher
operating costs and weaker margins that masked revenue growth.
Cubist Pharmaceuticals Inc.'s (CBST) second-quarter earnings
fell 65% as the biopharmaceutical company was hurt by higher costs
that more than offset double-digit revenue growth.
Cytec Industries Inc.'s (CYT) second-quarter profit slid 15% as
the specialty chemicals and materials company recorded a loss tied
to the sale of a coating-resins business it sold earlier this
year.
Reinsurance Group of America Inc. (RGA) swung to a steep
second-quarter loss, as the life reinsurer recorded a $184 million
after-tax charge related to increased claim liabilities in
Australia.
Synovus Financial Corp. (SNV) plans to sell $185 million of its
stock as part of its plan to repay about $968 million it had
received under the U.S. Treasury's Troubled Asset Relief Program
during the financial crisis.
Stryker Corp.'s (SYK) second-quarter profit fell 34% as the
medical-device maker recorded a $170 million charge tied to product
recalls, though sales grew.
TransMontaigne Partners L.P. (TLP) is launching an offering of
1.45 million shares, as it looks to repay debt and fund its share
of the construction of the Battleground Oil terminal project, its
joint venture with Kinder Morgan Energy Partners L.P. (KMP).
TransMontaigne had around 14.4 million shares outstanding as of
April 30.
Write to Nathalie Tadena at nathalie.tadena@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires